BMJ 2001;323:1022 ( 3 November )

News

How anthrax gets a grip on cells

Scott Gottlieb, New York
The first 150 words of the full text of this article appear below.

Scientists have identified the key structures of the anthrax bacterium that could lead to antitoxins and other treatments for the infection.

The research, some of it begun as long as five years ago, is fortuitously bearing fruit just as the disease is the focus of a biological terrorism scare in the United States. Any medicines arising from the work, however, will not appear for a year or two at the earliest, experts have said.

The National Institutes and the United States army are among the organisations starting to search for drugs based on the new studies, which will appear in the journal Nature this month but were released on the journal's website on 23 October (www.nature.com).

The anthrax toxin is composed of several distinct molecules. Before the toxin enters a cell, its parts---"oedema" factor, "lethal" factor, and seven copies of "protective" factor---bind together as a unit. They . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview